483
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

Silencing of HEATR1 contributes the synergistic effect of Feiyanning decoction and cisplatin on the inhibition of cell viability in A549/DDP cells

, , , , , & show all
Pages 1198-1207 | Received 22 Mar 2021, Accepted 03 Aug 2022, Published online: 24 Nov 2022

References

  • Amelio I, Inoue S, Markert EK, Levine AJ, Knight RA, Mak TW, Melino G. 2015. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1alpha degradation. Proc Natl Acad Sci USA. 112:226–231. Epub 2014/12/24.
  • Ang YL, Tan HL, Soo RA. 2015. Best practice in the treatment of advanced squamous cell lung cancer. Ther Adv Respir Dis. 9:224–235. Epub 2015/04/24.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. Epub 2018/09/13.
  • Bursac S, Jurada D, Volarevic S. 2018. New insights into HEATR1 functions. Cell Cycle. 17:143–144. Epub 2017/12/14.
  • Cao A, He H, Wang Q, Li L, An Y, Zhou X. 2019. Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis. Medicine (Baltimore). 98:e14798. Epub 2019/03/19.
  • Cui X, Wang S, Cao H, Guo H, Li Y, Xu F, Zheng M, Xi X, Han C. 2018. A review: The bioactivities and pharmacological applications of polygonatum sibiricum polysaccharides. Molecules. 23. Epub 2018/05/15.
  • Dai PC, Liu DL, Zhang L, Ye J, Wang Q, Zhang HW, Lin XH, Lai GX. 2017. Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6. Tumour Biol J Intern Soc Oncodevelop Biol Med. 39:1010428317697555. Epub 2017/04/27.
  • Flores ER. 2016. Commentary on “apoptosis, p53, and tumor cell sensitivity to anticancer agents”. Cancer Res. 1(76):6763–6764. Epub 2016/12/03.
  • Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang S. 2014. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (huangqi). Phytotherapy Res. 28:1275–1283. Epub 2014/08/05.
  • Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Petrella F, Spaggiari L, Rosell R. 2015. Non-small-cell lung cancer. Nat Rev Dis Prim. 21(1):15009. Epub 2015/01/01.
  • He S, Ma X, Ye Y, Zhang M, Zhuang J, Song Y, Xia W. 2019. HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway. OncoTarg Ther. 12:4001–4011. Epub 2019/06/14.
  • Ji H, Huang C, Wu S, Kasim V. 2019. XBP1-s promotes colorectal cancer cell proliferation by inhibiting TAp73 transcriptional activity. Biochem Biophys Res Commun. 508:203–209. Epub 2018/11/27.
  • Kawano Y, Ohyanagi F, Yanagitani N, Kudo K, Horiike A, Tanimoto A, Nishizawa H, Ichikawa A, Sakatani T, Nakatomi K, et al. 2013. Pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer in Japanese patients: phase II study. Anticancer Res. 33:3327–3333. Epub 2013/07/31.
  • Lai ST, Wang Y, Peng F. 2020. Astragaloside IV sensitizes non-small cell lung cancer cells to cisplatin by suppressing endoplasmic reticulum stress and autophagy. J Thor Dis. 12:3715–3724. Epub 2020/08/18.
  • Liu T, Roh SE, Woo JA, Ryu H, Kang DE. 2013. Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis. Cell Death Dis. 4:e476. Epub 2013/01/26.
  • Liu TY, Zhao LL, Chen SB, Hou BC, Huang J, Hong X, Qing L, Fang Y, Tao Z. 2020. Polygonatum sibiricum polysaccharides prevent LPS-induced acute lung injury by inhibiting inflammation via the TLR4/Myd88/NF-kappaB pathway. Exper Therap Med. 3733–3739. Epub 2020/08/29.
  • Nakamura M, Sugimoto H, Ogata T, Hiraoka K, Yoda H, Sang M, Sang M, Zhu Y, Yu M, Shimozato O, et al. 2016. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Oncogenesis. 5:e233. Epub 2016/06/15.
  • Nguyen CTT, Petrelli F, Scuri S, Nguyen BT, Grappasonni I. 2019. A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer. Eur J Health Econ. 20:763–777. Epub 2019/03/07.
  • Peirce SK, Findley HW. 2009. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73. Intern J Oncol. 34:1395–1402. Epub 2009/04/11.
  • Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. 2004. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 320:1103–1111. Epub 2004/07/14.
  • Wakelee H, Kelly K, Edelman MJ. 2014. 50 Years of progress in the systemic therapy of non-small cell lung cancer. In: Am Soc clin oncol educ book. p. 177–189. Epub 2014/05/27.
  • Wang N, Tan HY, Chan YT, Guo W, Li S, Feng Y. 2017. Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde. Oncotarget. 8:105848–105859. Epub 2017/12/30.
  • Wu ZB, Qiu C, Zhang AL, Cai L, Lin SJ, Yao Y, Tang QS, Xu M, Hua W, Chu YW, et al. 2014. Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma. J Immunol Res. 131494. Epub 2014/08/16.
  • Zhang P, Liu SS, Ngan HY. 2012. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells. PloS One. 7:e42985. Epub 2012/08/18.
  • Zhao LH, Ma ZX, Zhu J, Yu XH, Weng DP. 2011. Characterization of polysaccharide from Astragalus radix as the macrophage stimulator. Cell Immunol. 271:329–334. Epub 2011/09/23.
  • Zhou Y, Wang K, Zhou Y, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. 2020. HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling. Redox Biol. 29:101390. Epub 2019/12/01.